NICE Guidance by month - August 2014

Reference Guidance Programme Topic
HTDG13 NICE diagnostic support for viscoelastometric point-of-care testing (ROTEM, TEG and Sonoclot systems)
Health technologies adoption programme
QS66 Intravenous fluid therapy in adults in hospital
Quality standards
Acute and critical care
SFCQS66 NICE support for commissioning for intravenous fluid therapy in adults in hospital
Support for commissioning
Acute and critical care
SFCQS67 NICE support for commissioning for varicose veins in the legs
Support for commissioning
Varicose veins
QS67 Varicose veins in the legs
Quality standards
Varicose veins
DG13 Detecting, managing and monitoring haemostasis: viscoelastometric point‑of‑care testing (ROTEM, TEG and Sonoclot systems)
Diagnostics guidance
Surgical care
IPG499 Minimally invasive video-assisted thyroidectomy
Interventional procedure guidance
Thyroid disorders
IPG501 Minimally invasive video‑assisted parathyroidectomy
Interventional procedure guidance
Thyroid disorders
TA320 Dimethyl fumarate for treating relapsing‑remitting multiple sclerosis
Technology appraisal guidance
Multiple sclerosis
IPG500 Total prosthetic replacement of the temporomandibular joint
Interventional procedure guidance
Maxillofacial conditions
TAG In development  Breast cancer (HER2 positive, unresectable) - trastuzumab emtansine (after trastuzumab & taxane) [ID603]
Technology appraisals
Breast cancer
TAG In development  Anaemia (cancer-treatment induced) - erythropoiesis-stimulating agents (epoetin and darbepoetin) (inc rev TA142) [ID541]
Technology appraisals
Complications of cancer
Get involved